Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten

It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …

News
sanofi_regeneron

Sanofi and Regeneron’s projected blockbuster gains EU approval

September 28, 2017
Sales and Marketing Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …

News

Sanofi’s arthritis treatment Kevzara secures NICE recommendation

September 25, 2017
Sales and Marketing Kevzara, NICE, Sanofi, pharma, pharmaceutical, rheumatoid arthritis, sarilumab

Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its …

News
alnylam

Alnylam soars on likely first RNAi treatment approval

September 22, 2017
Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …

News

New therapy offers triple threat to HIV virus

September 22, 2017
Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …

News
sanofi_regeneron

Sanofi/Regeneron new asthma data bolstered by potential indications

September 13, 2017
Research and Development Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but …

News

Sanofi backs out of controversial Zika vaccine project

September 4, 2017
Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

News
governance_guenterpeter

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …

Appointment

Strong Q2 growth for Sanofi raises 2017 sales outlook

July 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dupixient, Sanofi, biotech, drugs, healthcare, pharma, pharmaceuticals

Sanofi exuded renewed confidence in its updated forecast for 2017 on the back of a Q2 report which illustrated strong …

News
sanofi-steve-oldfield

Department of Health appoints Teva and Sanofi veteran as commercial head

July 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, Sanofi, Teva, biotech, drugs, government, healthcare, pharma, pharmaceuticals

The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …

Appointment
de_clarens

Sanofi Pasteur Korea appoint new General Manager

July 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical

Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …

Appointment
merck_and_co

MSD’s Lantus biosimilar given conditional FDA approval

July 21, 2017
Medical Communications, Sales and Marketing FDA, MSD, Sanofi, biosimilar, biotech, drugs, pharma, pharmaceutical

MSD, known as Merck in North America, has been granted approval for its biosimilar of Sanofi’s diabetes treatment, Lantus. Potentially, …

News

Sanofi makes moves with strategic $2.4 billion Ablynx nanobody deal

July 20, 2017
Sales and Marketing Ablynx, Sanofi, biotech, drugs, nanobody, pharma, pharmaceutical

Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech …

News

Sanofi snatches up Protein Sciences for $750 million

July 11, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, acquisition, protein sciences

French drug maker Sanofi has announced that it has agreed to acquire vaccine biotech company Protein Sciences for a potential …

News
shutterstock_339308225

Revealing the missing evidence: Randomised real-life studies in basal insulin therapy

July 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025